Teva to pay $4.3B to settle opioid epidemic litigation with states

Teva and about a dozen states have agreed in principle to pay a maximum of $4.25 billion over 13 years (including the already settled cases for about $550 million) to settle opioid-related litigation that will also see the Israeli-based generic manufacturer pay another $100 million to Native American tribes.